|
Emily Hopewell PhD
Assistant Professor of Clinical Medical and Molecular Genetics, Director, Cell and Gene Therapy Manufacturing Chief Operations Officer, Brown Center for Immunotherapy
Indiana University
USA
|
Emily Hopewell began her career at the Moffitt Cancer Center as a technologist in the Cell Therapy Facility in 2003. She received her PhD in Cancer Biology from the University of South Florida in 2012. She joined Indiana University in 2018 as an Assistant Professor in Clinical Medical and Molecular Genetics She directs Cell and Gene Therapy Manufacturing (CGTM) and is the Chief Operations Officer of the Brown Center for Immunotherapy. The CGTM group comprises the Vector Production Facility, Cell Immunotherapy and Transduction Facility, and the Bioprocess Development Laboratory. Dr. Hopewell oversees all aspects of manufacturing, from development efforts to clinical production of cell and gene therapies for use in clinical trials. She provides leadership, strategic direction and input on education, research and clinical missions within the Cell and Gene Therapy GMP Facilities, the Department of Medical and Molecular Genetics, and the Brown Center for Immunotherapy.